Is surgery an option for early stage Liver Cancer

Surgery for Early-Stage Liver Cancer

Yes, surgery is absolutely an option for early-stage liver cancer, and according to the NCCN Guidelines for Hepatocellular Carcinoma, it's actually considered a potentially curative treatment for well-selected patients.

How Surgery Works for Early-Stage HCC

Partial hepatectomy (surgical removal of the cancerous portion of the liver) is the standard surgical approach. Here's what makes it effective:

• Best candidates: Patients with a solitary (single) tumor of any size with no evidence of vascular invasion (cancer spreading into blood vessels)
• Success rates: For selected patients with preserved liver function and early-stage disease, 5-year survival rates can reach approximately 70%
• Safety: Modern liver resection can now be performed with low operative risk (≤5% morbidity and mortality) when done by experienced surgeons

Important Considerations Before Surgery

Your surgical team will carefully evaluate several factors:

1. Liver Function

• Your liver must have adequate remaining function after surgery
• Doctors assess this using the Child-Turcotte-Pugh (CTP) score and liver function tests
• The "future liver remnant" (FLR)—the portion of liver that remains after surgery—must be at least 20-40% of your total liver volume, depending on whether you have cirrhosis

2. Overall Health

• Your performance status (ability to tolerate surgery)
• Age and comorbidities (other medical conditions)
• Presence of portal hypertension (high blood pressure in the liver's blood vessels)

3. Tumor Characteristics

• Size and location of the tumor
• Whether cancer has invaded blood vessels
• Number of tumors present

What Happens After Surgery

According to NCCN Guidelines, it's important to know that recurrence rates are significant—approximately 70% of patients experience recurrence within 5 years, either from new tumors or metastases (cancer spread). This is why:

• Close follow-up imaging is essential
• Some patients may benefit from adjuvant therapy (additional treatment after surgery)
• Your oncology team may recommend systemic therapy or other treatments depending on your specific pathology findings

Questions to Ask Your Healthcare Team

1. Am I a surgical candidate? What specific factors about my liver function and tumor make me suitable (or not suitable) for resection?

2. What is my future liver remnant percentage, and is it adequate? Will I need portal vein embolization (a procedure to help the remaining liver grow before surgery)?

3. What is the expected 5-year recurrence risk for my specific tumor characteristics? Will I need adjuvant therapy after surgery?

4. Should I see a hepatic surgeon (a surgeon specializing in liver surgery) for a second opinion?

5. What is your experience with HCC resection? How many cases do you perform annually?

The Multidisciplinary Approach

According to NCCN Guidelines, all patients with HCC should be evaluated by an experienced multidisciplinary team including hepatologists, surgeons, medical oncologists, interventional radiologists, and pathologists. This team approach ensures you get the most comprehensive evaluation of whether surgery is right for you.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.